Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-01-10
2000-05-23
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514510, 514824, A61K 31445, A61K 3121
Patent
active
060666536
ABSTRACT:
A method is provided for inhibiting or treating diseases associated with acid lipase deficiency by administering to a patient an MTP inhibitor, alone or optionally, in combination with another cholesterol lowering drug, such as pravastatin.
REFERENCES:
patent: 4346227 (1982-08-01), Terahara et al.
patent: 5712279 (1998-01-01), Biller et al.
Scriver et al "The Metabolic and Molecular Bases of Inherited Disease", Seventh Edition, vol. II, Chapter 82, "Acid Lipase Deficiency: Wolman Disease and Cholesteryl Ester Storage Disease", pp. 2563-2587, (1995).
Scriver et al "The Metabolic and Molecular Bases of Inherited Disease", Seventh Edition, vol. II, Chapter 85, "Niemann-Pick Disease Type C: A Cellular Cholesterol Lipidosis", pp. 2625-2639, (1995).
Gregg Richard E.
Wetterau, II John R.
Bristol-Myers Squibb Co.
Hermenau Ronald S.
Jordan Kimberly
Rodney Burton
LandOfFree
Method of treating acid lipase deficiency diseases with an MTP i does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating acid lipase deficiency diseases with an MTP i, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating acid lipase deficiency diseases with an MTP i will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1837334